ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 68 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $369,000 | +38.7% | 355,162 | -0.0% | 0.00% | – |
| Q4 2018 | $266,000 | -87.6% | 355,294 | -64.9% | 0.00% | – |
| Q3 2018 | $2,144,000 | -7.3% | 1,011,356 | +1.0% | 0.00% | – |
| Q2 2018 | $2,314,000 | -27.4% | 1,001,640 | -0.0% | 0.00% | – |
| Q1 2018 | $3,186,000 | -22.1% | 1,001,885 | +0.4% | 0.00% | – |
| Q4 2017 | $4,092,000 | -11.9% | 998,147 | -2.9% | 0.00% | – |
| Q3 2017 | $4,645,000 | +40.1% | 1,027,564 | +3.2% | 0.00% | – |
| Q2 2017 | $3,315,000 | -61.9% | 995,646 | +5.3% | 0.00% | – |
| Q1 2017 | $8,708,000 | +25.5% | 945,485 | +5.1% | 0.00% | – |
| Q4 2016 | $6,938,000 | -25.2% | 899,991 | +10.8% | 0.00% | -100.0% |
| Q3 2016 | $9,281,000 | +19.3% | 811,969 | +28.5% | 0.00% | – |
| Q2 2016 | $7,781,000 | +28.1% | 632,093 | +5.2% | 0.00% | – |
| Q1 2016 | $6,075,000 | -38.1% | 600,928 | +37.9% | 0.00% | -100.0% |
| Q4 2015 | $9,822,000 | +37.5% | 435,756 | +1.2% | 0.00% | – |
| Q3 2015 | $7,145,000 | -18.2% | 430,647 | +10.9% | 0.00% | -100.0% |
| Q2 2015 | $8,740,000 | -6.6% | 388,469 | +7.1% | 0.00% | 0.0% |
| Q1 2015 | $9,353,000 | +52.7% | 362,810 | +28.9% | 0.00% | – |
| Q4 2014 | $6,124,000 | +34.4% | 281,443 | +16.9% | 0.00% | – |
| Q3 2014 | $4,557,000 | +10.6% | 240,706 | +36.1% | 0.00% | – |
| Q2 2014 | $4,120,000 | -18.7% | 176,813 | +17.4% | 0.00% | – |
| Q1 2014 | $5,066,000 | +63.4% | 150,548 | +43.3% | 0.00% | – |
| Q4 2013 | $3,101,000 | +108.5% | 105,029 | +8.1% | 0.00% | – |
| Q3 2013 | $1,487,000 | – | 97,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|